Search

Your search keyword '"Rivière, Jacques G"' showing total 160 results

Search Constraints

Start Over You searched for: Author "Rivière, Jacques G" Remove constraint Author: "Rivière, Jacques G"
160 results on '"Rivière, Jacques G"'

Search Results

1. Correction: Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19

2. Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19

4. Lack of association between classical HLA genes and asymptomatic SARS-CoV-2 infection

6. Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths

7. JAK inhibitor treatment for inborn errors of JAK/STAT signaling: An ESID/EBMT-IEWP retrospective study

8. Multisystem inflammatory syndrome in children and SARS-CoV-2 variants: a two-year ambispective multicentric cohort study in Catalonia, Spain

9. The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies

10. Activated phosphoinositide 3-kinase δ syndrome: Update from the ESID Registry and comparison with other autoimmune-lymphoproliferative inborn errors of immunity

11. Treatments for multi-system inflammatory syndrome in children — discharge, fever, and second-line therapies

12. Epigenetic profiling linked to multisystem inflammatory syndrome in children (MIS-C): A multicenter, retrospective study

13. Heterozygous Predicted Loss-of-function Variants of TRAF3 in Patients with Common Variable Immunodeficiency.

14. Curation and expansion of Human Phenotype Ontology for defined groups of inborn errors of immunity

15. Determining value in the treatment of activated PI3Kδ syndrome in Spain: a multicriteria decision analysis from the perspective of key stakeholders

17. Overview of STING-Associated Vasculopathy with Onset in Infancy (SAVI) Among 21 Patients

18. Multisystem Inflammatory Syndrome in Children in Western Countries? Decreasing Incidence as the Pandemic Progresses?: An Observational Multicenter International Cross-sectional Study

19. Development of an Expert-Based Scoring System for Early Identification of Patients with Inborn Errors of Immunity in Primary Care Settings – the PIDCAP Project.

20. Executive Summary of the Consensus Document on the Diagnosis and Management of Patients with Primary Immunodeficiencies

21. Long-term outcome of LRBA deficiency in 76 patients after various treatment modalities as evaluated by the immune deficiency and dysregulation activity (IDDA) score

22. JAK inhibitor treatment for inborn errors of JAK/STAT signaling: An ESID/EBMT-IEWP retrospective study

23. Neuroinflammatory Disease as an Isolated Manifestation of Hemophagocytic Lymphohistiocytosis

25. JAK inhibitor treatment for inborn errors of JAK/STAT signaling: An ESID/EBMT-IEWP retrospective study

26. Multisystem inflammatory syndrome in children and SARS-CoV-2 variants: a two-year ambispective multicentric cohort study in Catalonia, Spain

27. Additional file 1 of Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19

28. Detection and evolutionary dynamics of somatic FAS variants in autoimmune lymphoproliferative syndrome: Diagnostic implications

29. Multisystem Inflammatory Syndrome in Children and SARS-CoV-2 variants: a two-year ambispective multicentric cohort study in Catalonia, Spain.

30. Treatments for multi-system inflammatory syndrome in children - discharge, fever, and second-line therapies

31. X-linked recessive TLR7 deficiency in ~1% of men under 60 years old with life-threatening COVID-19

32. Impact of JAK Inhibitors in Pediatric Patients with STAT1 Gain of Function (GOF) Mutations-10 Children and Review of the Literature

33. Multisystem inflammatory syndrome in children in western countries: decreasing incidence as the pandemic progresses? An observational multicenter international cross-sectional study

34. The risk of COVID-19 death is much greater and age-dependent with type I IFN autoantibodies

35. Inborn errors of TLR3- or MDA5-dependent type I IFN immunity in children with enterovirus rhombencephalitis

36. SARS-CoV-2-related MIS-C:A key to the viral and genetic causes of Kawasaki disease?

37. Early Diagnosis and Treatment of Purine Nucleoside Phosphorylase (PNP) Deficiency through TREC-Based Newborn Screening

39. Multi-inflammatory Syndrome in Children Related to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Spain

40. Newborn Screening for SCID. Experience in Spain (Catalonia)

41. Activation-induced deaminase is critical for the establishment of DNA methylation patterns prior to the germinal center reaction

42. X-linked recessive TLR7 deficiency in ~1% of men under 60 years old with life-threatening COVID-19

43. Activation-induced deaminase is critical for the establishment of DNA methylation patterns prior to the germinal center reaction

44. X-linked recessive TLR7 deficiency in ~1% of men under 60 years old with life-threatening COVID-19.

45. X-linked recessive TLR7 deficiency in ~1% of men under 60 years old with life-threatening COVID-19

46. Executive Summary of the Consensus Document on the Diagnosis and Management of Patients with Primary Immunodeficiencies

49. Uncovering Low-Level Maternal Gonosomal Mosaicism in X-Linked Agammaglobulinemia: Implications for Genetic Counseling

50. Uncovering Low-Level Maternal Gonosomal Mosaicism in X-Linked Agammaglobulinemia : Implications for Genetic Counseling

Catalog

Books, media, physical & digital resources